Know Cancer

or
forgot password

Epidemiological Study to Describe NSCLC Clinical Management Patterns in MENA


N/A
18 Years
N/A
Open (Enrolling)
Both
Non Small Cells Lung Cancer

Thank you

Trial Information

Epidemiological Study to Describe NSCLC Clinical Management Patterns in MENA


Epidemiological study to describe NSCLC clinical management patterns in MENA


Inclusion Criteria:



- Confirmed NSCLC diagnosis (e.g. bronchoscope or FNAB), all stages, men and women,
attending the responsible department of treating this type of patients for the first
time between November 1st, 2011 and August 30th, 2012 For PRO

- Sub-sample:

- ability to read and write since they will be asked to participate in the PRO
part of the study.

- Selection will not be based on the disease stage of each patient, in order to avoid a
selection bias.

Exclusion Criteria:

- According to the study design there will not be any exclusion criteria in order to
provide a high validity and to obtain the most accurate real daily practice
information.

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

Use of health resources by collecting data about hospital description and characteristics, Disease Diagnosis Procedures and Therapy information

Outcome Time Frame:

April 2014(26 Months)

Safety Issue:

No

Principal Investigator

Kakil Rasul, CONSULTANT

Investigator Role:

Principal Investigator

Investigator Affiliation:

Hamad Medical Corporation, Doha, Qatar

Authority:

United Arab Emirates: Drug Control Department - Medicines and Pharmacy Control - Ministry of Health

Study ID:

NIS-OAE-XXX-2011/1

NCT ID:

NCT01562665

Start Date:

February 2012

Completion Date:

December 2013

Related Keywords:

  • Non Small Cells Lung Cancer
  • All patients with NSCLC attending participating hospitals
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms

Name

Location